Search Results - "Powers, Chelsea N."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever by Powers, Chelsea N, Setzer, William N

    “…A virtual screening analysis of our library of phytochemical structures with dengue virus protein targets has been carried out using a molecular docking…”
    Get more information
    Journal Article
  2. 2

    Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils by Powers, Chelsea N, Osier, Jessica L, McFeeters, Robert L, Brazell, Carolyn Brianne, Olsen, Emily L, Moriarity, Debra M, Satyal, Prabodh, Setzer, William N

    Published in Molecules (Basel, Switzerland) (27-06-2018)
    “…There is an urgent and unmet need for new antifungal therapies. Global fungal infection rates continue to rise and fungal infections pose increasing burdens on…”
    Get full text
    Journal Article
  3. 3

    Bigger Data Approach to Analysis of Essential Oils and Their Antifungal Activity against Aspergillus niger , Candida albicans , and Cryptococcus neoformans by Powers, Chelsea N, Satyal, Prabodh, Mayo, John A, McFeeters, Hana, McFeeters, Robert L

    Published in Molecules (Basel, Switzerland) (07-08-2019)
    “…With increasing drug resistance and the poor state of current antifungals, the need for new antifungals is urgent and growing. Therefore, we tested a variety…”
    Get full text
    Journal Article
  4. 4

    Essential Oil Compositions and Antifungal Activity of Sunflower (Helianthus) Species Growing in North Alabama by Lawson, Sims K., Sharp, Layla G., Powers, Chelsea N., McFeeters, Robert L., Satyal, Prabodh, Setzer, William N.

    Published in Applied sciences (01-08-2019)
    “…Helianthus species are North American members of the Asteraceae, several of which have been used as traditional medicines by Native Americans. The aerial parts…”
    Get full text
    Journal Article
  5. 5

    Volatile Compositions and Antifungal Activities of Native American Medicinal Plants: Focus on the Asteraceae by Lawson, Sims K, Sharp, Layla G, Powers, Chelsea N, McFeeters, Robert L, Satyal, Prabodh, Setzer, William N

    Published in Plants (Basel) (19-01-2020)
    “…In the past, Native Americans of North America had an abundant traditional herbal legacy for treating illnesses, disorders, and wounds. Unfortunately, much of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Chemical Composition, Enantiomeric Distribution, and Antifungal Activity of the Oleoresin Essential Oil of Protium amazonicum from Ecuador by Satyal, Prabodh, Powers, Chelsea N, Parducci V, Rafael, McFeeters, Robert L, Setzer, William N

    Published in Medicines (Basel, Switzerland) (23-09-2017)
    “…species (Burseraceae) have been used in the treatment of various diseases and conditions such as ulcers and wounds. The essential oil from the oleoresin of was…”
    Get full text
    Journal Article
  8. 8

    Retrospective evaluation of erlotinib and gefitinib used in the military health system from the perspective of drug-drug interactions by Shou, Karen J, Luong, Thu-Lan T., Powers, Chelsea N., Reinhardt, Brian J., McAnulty, Mike J., Weina, Peter J.

    Published in Journal of clinical oncology (01-06-2023)
    “…e15108 Background: Erlotinib and gefitinib are epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) approved primarily for non-small cell…”
    Get full text
    Journal Article
  9. 9

    A molecular docking study of phytochemical estrogen mimics from dietary herbal supplements by Powers, Chelsea N, Setzer, William N

    Published in In silico pharmacology (22-03-2015)
    “…Purpose The purpose of this study is to use a molecular docking approach to identify potential estrogen mimics or anti-estrogens in phytochemicals found in…”
    Get full text
    Journal Article
  10. 10

    Retrospective Evaluation of Drug-Drug Interactions With Erlotinib and Gefitinib Use in the Military Health System by Luong, Thu-Lan T, Powers, Chelsea N, Reinhardt, Brian J, McAnulty, Michael J, Weina, Peter J, Shou, Karen J, Ambar, Caban B

    Published in Federal practitioner (01-08-2023)
    “…BackgroundErlotinib and gefitinib are epidermal growth factor receptor-tyrosine kinase inhibitors approved for non-small cell lung cancer treatment by the US…”
    Get full text
    Journal Article